UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comprehensive analyses of tumor immunity: implications for cancer immunotherapy

Genome Biology, 2016-08, Vol.17 (1), p.174-174, Article 174

2016

Volltextzugriff (PDF)

Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure)

Annals of oncology, 2016-08, Vol.27 (8), p.1492-1504

2016

Volltextzugriff (PDF)

A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer

Cancer Immunology, Immunotherapy, 2019-05, Vol.68 (5), p.799-812

2019

Volltextzugriff (PDF)

Current advances in bacteria‐based cancer immunotherapy

European journal of immunology, 2024-02, Vol.54 (2), p.e2350778-n/a

2024

Volltextzugriff (PDF)

Preclinical Evaluation of Chimeric Antigen Receptor-Modified T Cells Specific to Epithelial Cell Adhesion Molecule for Treating Colorectal Cancer

Human gene therapy, 2019-04, Vol.30 (4), p.402-412

2019

Volltextzugriff (PDF)

Combined nano cancer immunotherapy based on immune status in a tumor microenvironment

Journal of controlled release, 2022-05, Vol.345, p.200-213

2022

Volltextzugriff (PDF)

Sequential MR Image‐Guided Local Immune Checkpoint Blockade Cancer Immunotherapy Using Ferumoxytol Capped Ultralarge Pore Mesoporous Silica Carriers after Standard Chemotherapy

Small (Weinheim an der Bergstrasse, Germany), 2019-12, Vol.15 (52), p.e1904378-n/a

2019

Volltextzugriff (PDF)

Health‐related quality‐of‐life assessment of patients with solid tumors on immuno‐oncology therapies

Cancer, 2021-05, Vol.127 (9), p.1360-1368

2021

Volltextzugriff (PDF)

Transformable Nanosensitizer with Tumor Microenvironment‐Activated Sonodynamic Process and Calcium Release for Enhanced Cancer Immunotherapy

Angewandte Chemie International Edition, 2021-06, Vol.60 (25), p.14051-14059

International ed. in English, 2021

Volltextzugriff (PDF)

Cancer Immunotherapy: A Focus on the Regulation of Immune Checkpoints

International journal of molecular sciences, 2018-05, Vol.19 (5), p.1389

2018

Volltextzugriff (PDF)

Deciphering CD137 (4‐1BB) signaling in T‐cell costimulation for translation into successful cancer immunotherapy

European journal of immunology, 2016-03, Vol.46 (3), p.513-522

2016

Volltextzugriff (PDF)

Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy

Journal of hematology and oncology, 2024-04, Vol.17 (1), p.16-16, Article 16

2024

Volltextzugriff (PDF)

Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors

Biology (Basel, Switzerland), 2023-01, Vol.12 (2), p.218

2023

Volltextzugriff (PDF)

T cells, NK cells, and tumor-associated macrophages in cancer immunotherapy and the current state of the art of drug delivery systems

Frontiers in immunology, 2023-06, Vol.14, p.1199173-1199173

2023

Volltextzugriff (PDF)

Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug

Cancer science, 2018-03, Vol.109 (3), p.587-599

2018

Volltextzugriff (PDF)

Nanomedicine for improvement of dendritic cell-based cancer immunotherapy

International immunopharmacology, 2020-06, Vol.83, p.106446, Article 106446

2020

Volltextzugriff (PDF)

Development of Cancer Immunotherapies

Cancer Immunotherapies, 2022, Vol.183, p.1-48

2022

Volltextzugriff (PDF)

Targeted Nano-Drug Delivery of Colchicine against Colon Cancer Cells by Means of Mesoporous Silica Nanoparticles

Cancers, 2020-01, Vol.12 (1), p.144

2020

Volltextzugriff (PDF)

HDAC6 inhibitor ACY-1215 enhances STAT1 acetylation to block PD-L1 for colorectal cancer immunotherapy

Cancer Immunology, Immunotherapy, 2024-01, Vol.73 (1), p.7-7, Article 7

2024

Volltextzugriff (PDF)

Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα–CD47 innate immune checkpoint

Journal for immunotherapy of cancer, 2019-12, Vol.7 (1), p.340-340, Article 340

2019

Volltextzugriff (PDF)

Regulatory T Cells in Cancer

Annual review of cancer biology, 2020-03, Vol.4 (1), p.459-477

2020

Volltextzugriff (PDF)

Transforming cancer care: Immunotherapy with advanced drug delivery

Journal of drug delivery science and technology, 2024-06, Vol.96, p.105670, Article 105670

2024

Volltextzugriff (PDF)

An infodemiology study on exploring the quality and reliability of colorectal cancer immunotherapy information

Digital health, 2023-01, Vol.9, p.20552076231205286-20552076231205286

2023

Volltextzugriff (PDF)

Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling

Cancer research (Chicago, Ill.), 2017-09, Vol.77 (17), p.4562-4566

2017

Volltextzugriff (PDF)

CIMT 2024: Report on the 21st Annual Meeting of the Association for Cancer Immunotherapy

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2381925

2024

Volltextzugriff (PDF)

1 – 25 von 113.730

Suche als RSS-Feed

Aktive Filter

PublikationsformBücher

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90.033)
Mit Volltextzugriff
(85.514)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(112.559)
Japanisch
(8.641)
Französisch
(308)
Chinesisch
(280)
Deutsch
(279)
Russisch
(94)
Spanisch
(94)
Portugiesisch
(89)
Norwegisch
(63)
Türkisch
(41)
Koreanisch
(35)
Polnisch
(21)
Urdu
(21)
Tschechisch
(11)
Italienisch
(11)
Persisch
(5)
Croatian
(4)
Dänisch
(4)
Serbian
(4)
Niederländisch
(3)

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Immunotherapy
(102.370)
Science & Technology
(80.147)
Life Sciences & Biomedicine
(73.163)
Oncology
(45.002)
Cancer
(44.920)
Humans
(44.902)
Tumors
(37.876)
Cancer Therapies
(29.972)
Patients
(24.338)
Chemotherapy
(23.606)
Metastasis
(20.983)
Lymphocytes
(20.766)
Immunology
(19.638)
Monoclonal Antibodies
(16.854)
Antigens
(16.661)
Animals
(16.512)
Clinical Trials
(16.292)
Medical Prognosis
(15.819)
Female
(15.730)
Lung Cancer
(13.352)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Free E-Journals
(61.496)
MEDLINE
(49.615)
IngentaConnect
(44.539)
IngentaConnect Journals
(30.068)
Journals@Ovid Full Text
(26.945)
Springer Journals
(24.013)
Nexis Uni (LexisNexis)
(21.915)
Wiley Online Library
(10.978)
ScienceDirect
(9.127)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(8.859)
NUS Single-Journal Subscriptions
(8.790)
British Medical Journals Online Archive (BMJ)
(7.524)
Taylor & Francis Journals Auto-Holdings Collection
(6.420)
North East Research Libraries Nature Academic Titles
(6.367)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(6.296)
Wiley Online Library Full Collection 2018
(5.910)
Taylor & Francis Current Content Access
(4.389)
Taylor & Francis:Master (3349 titles)
(2.619)
SAGE Journals
(1.338)
Business Source Ultimate
(924)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal For Immunotherapy Of Cancer
(6.091)
Cancers
(3.979)
Cancer Immunology, Immunotherapy
(2.986)
Cancer Immunology Immunotherapy
(2.762)
Cancer Immunology, Immunotherapy : Cii
(2.385)
Pr Newswire
(2.167)
Business Wire
(2.047)
International Journal Of Molecular Sciences
(1.791)
Plos One
(1.719)
Frontiers In Immunology
(1.680)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Comprehensive analyses of tumor immunity: implications for cancer immunotherapy

Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure)

A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer

Current advances in bacteria‐based cancer immunotherapy

Preclinical Evaluation of Chimeric Antigen Receptor-Modified T Cells Specific to Epithelial Cell Adhesion Molecule for Treating Colorectal Cancer

Combined nano cancer immunotherapy based on immune status in a tumor microenvironment

Sequential MR Image‐Guided Local Immune Checkpoint Blockade Cancer Immunotherapy Using Ferumoxytol Capped Ultralarge Pore Mesoporous Silica Carriers after Standard Chemotherapy

Health‐related quality‐of‐life assessment of patients with solid tumors on immuno‐oncology therapies

Transformable Nanosensitizer with Tumor Microenvironment‐Activated Sonodynamic Process and Calcium Release for Enhanced Cancer Immunotherapy

Cancer Immunotherapy: A Focus on the Regulation of Immune Checkpoints

Deciphering CD137 (4‐1BB) signaling in T‐cell costimulation for translation into successful cancer immunotherapy

Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy

Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors

T cells, NK cells, and tumor-associated macrophages in cancer immunotherapy and the current state of the art of drug delivery systems

Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug

Nanomedicine for improvement of dendritic cell-based cancer immunotherapy

Development of Cancer Immunotherapies

Targeted Nano-Drug Delivery of Colchicine against Colon Cancer Cells by Means of Mesoporous Silica Nanoparticles

HDAC6 inhibitor ACY-1215 enhances STAT1 acetylation to block PD-L1 for colorectal cancer immunotherapy

Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα–CD47 innate immune checkpoint

Regulatory T Cells in Cancer

Transforming cancer care: Immunotherapy with advanced drug delivery

An infodemiology study on exploring the quality and reliability of colorectal cancer immunotherapy information

Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling

CIMT 2024: Report on the 21st Annual Meeting of the Association for Cancer Immunotherapy

Aktive Filter

Suchergebnisse filtern